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The purpose of this study is to determine the value of Tc-99m HMPAO SPECT in the diagnosis of the dementias. Tc-99m
HMPAO was used with a 3-camera scanner to produce 5 sets of sectional images of the brain. Images were further processed using
Statistical Parametric Mapping. Diagnosis was made by a physician blinded to the clinical diagnosis. Results in 73 subjects were
comparedwitha neuropathologicstudy ofthebrainatautopsy.Data were analyzed forsensitivity, speciﬁcity, positive andnegative
predictive values and accuracy. These results are compared with several other studies performed with Tc-99m HMPAO SPECT
with histopathologiccorrelation. This procedure is widely availableandrelatively inexpensive and maybe ofvalue in patients with
dementiasandproblematic diagnoses.Further, a degree ofdiﬀerential diagnosisbetween Alzheimer’sandFrontotemporal diseases
may be eﬀected. The study was approved by our Institutional Review Board.
1.Introduction
This is one of a continuing series [3–7] of reports on a group
of patients studied with Tc-99m hexamethylpropyleneamine
oxime (HMPAO, Mallinckrodt, Inc.) SPECT brain blood
ﬂow. This paper will add 24 patients to the previously
described series and will constitute the ﬁnal report on this
imaging study.
2.Materialsand Methods
SPECTwas carried out with a three-camera scanner (PRISM
Picker 3000, Cleveland, OH) and a tracer dose of 740MBq
of Tc-99m HMPAO. After intravenous administration, a
period of 90m was allowed for distribution of the agent.
The patient then was asked to recline on a couch with
comfortable bracing of the head within the detection space
of the scanner. Data were acquired with high-resolution
fan-beam collimators in a 128 × 128 matrix. Data sets
were acquired at 3◦ intervals for 30s each, to a total of
40 sets. Correction for fan-beam collimator geometry was
made during acquisition. Data were reconstructed as 12.5-
cm-radius cylinders. Data were then multiplied by a factor
of 4 and processed with a Ramp ﬁlter, with a pixel size of
1.89mm. Attenuation correction was applied. Postﬁltering
was carried out with a three-dimensional pass ﬁlter with
an upper limit of 10 and a cutoﬀ of 2.49. With use of a
pixel size of 5–7mm, contiguous transaxial sections were
generatedparallel tothe canthomeatal line,as well ascoronal
and sagittal views. Two special temporal sections were also
generated. Initially, scans were displayed in a color scale of
the “heatedbody” type, butthe ﬁnal 49/73caseswere further
processed using Statistical Parametric Mapping [1, 2]. Data
were reoriented parallel to a plane passing through the
anterior and posterior commissures and were sectioned to
produce the ﬁve views described above. SPM patient image2 International Journal of Molecular Imaging
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Figure 1: The patient was a 64-year-old male.An SPECT scanwas performed as described and further processed with SPM [1, 2].The areas
of interest displayed in yellow represent groups of voxels within which regional blood ﬂow was below normal; P is ≤.001. Three transaxial
sectionswere selected fromagroupof24.Image(a)showsreduced ﬂowinasmallvolumeofthelefthippocampus(→).(b) ↑showsreduced
RCBF in the left caudate and adjacent lateral frontal cortex (↑). The lower arrow indicates reduced ﬂow in the left posterior temporal and
occipital regions. (c) There is reduced RCBF in the posterior cingulate cortex (↑) .L e f tf r o n t a la n db i l a t e r a lp a r i e t a lr e g i o n so fl o wﬂ o wa r e
also noted.
datawerethencomparedwiththesummedimagesofnormal
20 volunteers for interpretation (see Figure 1).
An example of the application of this method may be
seen in the case represented by Figure 1.A su s u a l ,t h e
clinical state of the patient was unknown to the interpreter
of the study images. The 3 images are transaxial sections
selected from the study of a 64-year-old male performed as
described above. The SPECT data were then processed by
SPManddisplayedsoastoshow brainvolumeswithin which
regional cerebral blood ﬂow (RCBF) was reduced below the
value derived from the group of 20 normal volunteers in a
suitable age group, with a statistical signiﬁcance of P being
≤.001. The ﬁndings of reduced RCBF in the hippocampus,
temporal, and parietal lobes, together with the important
ﬁnding of ﬂow reduction in the posterior cingulate cortex, a
ﬁnding seen almost exclusively with AD, and reduced RCBF
is also seen in the left caudate nucleus, and in the inferior
occipital cortex (→B). The latter distribution suggests the
possibility of a component of Lewy body disease. Pathologic
ﬁndings supported the scan diagnosis of AD with possible
Parkinson’s disease, with ma n yL e w yb o d i e sp r e s e n t .
The interval between scan and autopsy was from 1m to
181m (mean = 71.1m)
3.Resultsand Discussion
The results of this series are summarized in Table 1 in terms
of the diagnosis of AD, with or without Lewy bodies. In
termsofcorrelationwith histopathology,SPECTﬁndings are
given as true positive, true negative, false positive and false
negative.
Table 1: Diagnosis of AD with or without Lewy body disease.
True positive 44
True negative 22
False positive 4
False negative 3
Table 2 :F o rt h ed i a g n o s i so fA Dw i t ho rw i t h o u tL e w yb o d i e s .
Proportion
95% Conﬁdence interval
Lower limit Upper limit
Sensitivity: 44/47 = 93.62% 81.44% 98.34%
Speciﬁcity: 22/26 = 84.62% 64.27% 94.95%
Positive predictive value:
44/48 = 91.67%
79.13% 97.30%
Negative predictive value:
22/25 = 88.00%
67.66% 96.85%
Accuracy: 66/73 = 90.41% 80.67% 95.73%
Table 2 shows statistical evaluation of the ﬁndings in
Table 1 in terms of proportion, with 95% conﬁdence inter-
vals, for sensitivity, speciﬁcity, positive predictive value,
negative predictive value and accuracy.
In the latter part of this study, an eﬀort was made
to evaluate the possibility of a diagnostic track for Fron-
totemporal disease. Results suggested the possibility of such
at r a c k ,b u ta ni n s u ﬃcient number of cases in this study
prevent valid statistical evaluation. In any case, ﬁndings
in the Frontotemporal group would probably not permit
diﬀerential diagnosis among the various entities.International Journal of Molecular Imaging 3
The results of this study were compared with those
of 2 previous studies which were performed with Tc-99m
HMPAO SPECT, with autopsy conﬁrmation [8–10]. In these
studies, accuracy in the detection of AD was approximately
80%. Accuracy in the present study is approximately 90%.
The apparent improvement is probably due to increasing
quality of SPECT instruments together with scan data treat-
ment with Statistical Parametric Mapping. This procedure
facilitates the identiﬁcation of brain volumes in which
signiﬁcant reduction of RCBF has occurred. It is especially
helpful in the detection of ﬂow reduction in the posterior
cingulate cortex [11] ,w h i c hi sas t r o n gm a r k e rf o rA D ,
when present [7]. SPECT brain imaging in the dementias
remains a relatively inexpensive procedure, compared with
the several applications of PET, and would probably be a
satisfactory substitute when PET with one of the newer
agents is unavailable. Again, however, the small size of our
patient group does not permit us to make statistical valid
conclusions relative to the value of SPECT.
4.Conclusions
SPECT brain blood ﬂow imaging has the ability to detect
active Alzheimer’s disease with approximately 90% accuracy.
It can be postulated that this technique is capable of
diﬀerential diagnosis between AD and the Frontotemporal
dementias. Further, interpretation of the scan data may
be enhanced by a treatment such as Statistical Parametric
Mapping. However, we do not believe that the number of
patients in our study group permits us to claim statistical
signiﬁcance. Further, the considerable variation in time
elapsed between scan and autopsy among the patient group
does not permit us to evaluate the role of this study in the
detection of early disease.
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